Literature DB >> 7635798

Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!

S M Bentzen, M Vaeth, D E Pedersen, J Overgaard.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7635798     DOI： 10.1016/0360-3016(95)00262-W

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  The use and interpretation of competing risks regression models.

Authors:  James J Dignam; Qiang Zhang; Masha Kocherginsky
Journal:  Clin Cancer Res       Date:  2012-01-26       Impact factor: 12.531

2.  A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.

Authors:  G Brandon Gunn; Eugene J Endres; Brent Parker; Maria Pia Sormani; Giuseppe Sanguineti
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

3.  Choice and interpretation of statistical tests used when competing risks are present.

Authors:  James J Dignam; Maria N Kocherginsky
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

4.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

5.  How to handle mortality when investigating length of hospital stay and time to clinical stability.

Authors:  Guy N Brock; Christopher Barnes; Julio A Ramirez; John Myers
Journal:  BMC Med Res Methodol       Date:  2011-10-26       Impact factor: 4.615

6.  STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.

Authors:  Sarah L Kerns; Dirk de Ruysscher; Christian N Andreassen; David Azria; Gillian C Barnett; Jenny Chang-Claude; Susan Davidson; Joseph O Deasy; Alison M Dunning; Harry Ostrer; Barry S Rosenstein; Catharine M L West; Søren M Bentzen
Journal:  Radiother Oncol       Date:  2013-08-27       Impact factor: 6.280

7.  Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.

Authors:  Cora Waldstein; Wolfgang Dörr; Richard Pötter; Joachim Widder; Gregor Goldner
Journal:  Strahlenther Onkol       Date:  2017-09-19       Impact factor: 3.621

Review 8.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

Authors:  Gillian C Barnett; Catherine M L West; Alison M Dunning; Rebecca M Elliott; Charlotte E Coles; Paul D P Pharoah; Neil G Burnet
Journal:  Nat Rev Cancer       Date:  2009-01-16       Impact factor: 60.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.